SEC Form 4 · accession 0001013762-15-000729
DelMar Pharmaceuticals, Inc. · DMPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Bacha
Officer — President, CEO · Director · 10% Owner
Period of report
Jul 16, 2015
Accepted (ET)
Jul 16, 2015 · 7:05 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001498382
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 16, 2015 | P | 50,000 | $0.60 | A | 113,485 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $0.75 | Jul 16, 2015 | P | 50,000 | A | Jul 16, 2015 | Jul 16, 2020 | Common Stock | 50,000 | 50,000 | D |